Browse > Article

Real-Time PCR for Validation of Minute Virus of Mice Safety during the Manufacture of Mammalian Cell Culture-Derived Biopharmaceuticals  

Lee, Dong-Hyuck (Department of Biological Sciences, Hannam University)
Cho, Hang-Mee (Department of Biological Sciences, Hannam University)
Kim, Hyun-Mi (Department of Biological Sciences, Hannam University)
Lee, Jung-Suk (Tissue Engineering Division, Research and Development Dept., Hans Daedeok R&D Center, Hans Biomed Corp.)
Kim, In-Seop (Department of Biological Sciences, Hannam University)
Publication Information
Microbiology and Biotechnology Letters / v.36, no.1, 2008 , pp. 12-20 More about this Journal
Abstract
Validation of viral safety is essential in ensuring the safety of mammalian cell culture-derived biopharmaceuticals, because numerous adventitious viruses have been contaminated during the manufacture of the products. Mammalian cells are highly susceptible to minute virus of mice(MVM), and there are several reports of MVM contamination during the manufacture of biopharmaceuticals. In order to establish the validation system for the MVM safety, a real-time PCR method was developed for quantitative detection of MVM in cell lines, raw materials, manufacturing processes, and final products as well as MVM clearance validation. Specific primers for amplification of MVM DNA was selected, and MVM DNA was quantified by use of SYBR Green I. The sensitivity of the assay was calculated to be $6{\times}10^{-2}TCID_{50}/mL$. The real-time PCR method was proven to be reproducible and very specific to MVM. The established real-time PCR assay was successfully applied to the validation of Chinese hamster ovary (CHO) cell artificially infected with MVM. MVM DNA could be Quantified in CHO cell as well as culture supernatant. When the real-time PCR assay was applied to the validation of virus removal during a virus filtration process, the result was similar to that of virus infectivity assay. Therefore, it was concluded that this rapid, specific, sensitive, and robust assay could replace infectivity assay for detection and clearance validation of MVM.
Keywords
Chinese hamster ovary (CHO) cell; minute virus of mice; real-time PCR; virus validation;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Adamson, S. R. 1999. Experiences of virus, retrovirus and retrovirus-like particles in chinese hamster ovary (CHO) and hybridoma cells used for production of protein therapeutics. Dev. Biol. Stand. 93: 89-96
2 Jeong, H.-S., J,-H. Shin, Y.-N. Park, J.-Y. Choi, Y.-L. Kim, B.-G. Kim, S.-R. Ryu, S.-Y. Baek, S.-H. Lee, and S.-N. Park. 2003. Development of real-time RT-PCR for evaluation of JEV clearance during purification of HPV type 16 L1 viruslike particles. Biologicals 31: 223-229   DOI   ScienceOn
3 Kim, S. H and G. M. Lee. 2007. Differences in optimal pH and temperature for cell growth and antibody production between two Chinese hamster ovary clones derived from the same parental clone. J. Microbiol. Biotechnol. 17: 712-720   과학기술학회마을
4 Park, S., J. Lee, B. Lee, and H. Kang. 2006. Production of humanised anti-hepatitis B antibody in butyrate-treated chinese hamster ovary cells. Kor. J. Microbiol. Biotechnol. 34: 47-51   과학기술학회마을
5 Parkman, P. D. 1996. Safety of biopharmaceuticals: a current perspective. Dev. Biol. Stand. 88: 5-7   PUBMED
6 Shin, J. S., Y. W. Choi, H. M. Sung, Y.-W. Ryu, and I. S. Kim. 2006. Enhanced virus safety of a solvent/detergenttreated antihemophilic factor IX concentrate by dryheattreatment. Biotechnol. Bioprocess Eng. 11: 19-25   과학기술학회마을   DOI   ScienceOn
7 Kraft, V. and B. Meyer. 1986. Diagnosis of murine infections in relation to test methods employed. Lab. Anim. Sci. 36: 271-276   PUBMED
8 Ryu, S.-R., J.-H. Shin, S.-Y. Baek, J.-O. Kim, K.-I. Min, B.- S. Min, B.-G. Kim, D.-K. Kim, M.-K. Park, M.-J. Ahn, K.- S. Chae, H.-S. Jeong, S.-H. Lee, and S.-N. Park. 2003 Evaluation of limit of detection and range of quantitation for RT-PCR, real-time RT-PCR and RT-PCR-ELISA detection of bovine viral diarrhea virus contamination in biologics derived from cell cultures. J. Bacteriol. Virol. 33: 161-168
9 Cotmore, S. F. and P. Tattersall. 1987. The autonomously replicating parvoviruses of vertebrates. Adv. Virus Res. 33: 91-174   DOI
10 International Conference on Harmonisation. 1998. Guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability. Federal Resister 63: 51074-51084
11 Chang, A., S. Havas, F. Borellini, J. M. Ostrove, and R. E. Bird. 1997. A rapid and simple procedure to detect the presence of MVM in conditioned cell fluids or culture media. Biologicals 25: 415-419   DOI   ScienceOn
12 Kilham, L. and G. Margolis. 1971. Fetal infections of hamsters, rats, and mice induced with the minute virus of mice (MVM). Teratology 4: 43-61   DOI   ScienceOn
13 Kilham, L. and G. Margolis. 1970. Pathogenicity of minute virus of mice (MVM) for rats, mice, and hamsters. Proc. Soc. Exp. Biol. Med. 133: 1447-1452
14 Darling, A. 2002. Validation of biopharmaceutical purification process for virus clearance evaluation. Mol. Biotechnol. 21: 57-83   DOI   ScienceOn
15 Garnick, R. L. 1998. Raw materials as a source of contamination in large-scale cell culture. Dev. Biol. Stand. 93: 21-29   PUBMED
16 Kajioka, J., R. Taguchi, and D. Nagaki. 1974. Plaque formation and replication of minute virus of mice. Kitasato Arch. Exp. Med. 47: 101-105   PUBMED
17 Zhan, D., M. R. Roy, C. Valera, J. Cardenas, J. C. Vennari, J. W. Che, and S. Liu. 2002. Detection of miute virus of mice using real time Quantitative PCR in assessment of virus clearance during the purification of mammalian cell substrate derived biotherapeutics. Biologicals 30: 259-270   DOI   ScienceOn
18 Garnick, R. L. 1996. Experience with viral contamination in cell culture. Dev. Biol. Stand. 88: 49-56   PUBMED
19 Arden, N. and M. J. Betenbaugh. 2004. Life and death in mammalian cell culture: strategies for apoptosis inhibition. Trends Biotechnol. 22: 174-180.   DOI   ScienceOn
20 Celis, P. and G. Silvester. 2004. European regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products. Dev. Biol. Stand. 118: 3-10
21 Kil, T. G., W. J. Kim, D. H. Lee, Y. Kang, H. M. Sung, S. H. Yoo, S.-N. Park, and I. S. Kim. 2005. Quantitative real-time PCR of porcine parvovirus as a model virus for cleaning validation of chromatography during manufacture of plasma derivatives. Kor. J. Microbiol. 41: 216-224   과학기술학회마을
22 Parker, J. C., S. S. Cross, M. J. Collins Jr, and W. P. Rowe. 1970. Minute virus of mice : procedures for quantification and detection. J. Natl. Cancer Inst. 45: 2973-303
23 Merten, O.-W. 2002. Virus contamination of cell cultures-a biotechnological view. Cytotechnol. 39: 91-116   DOI   ScienceOn
24 Walsh, G. 2002. Proteins: Biochemistry and Biotechnology, pp. 196-209. John Wiley & Sons Ltd, Baffins Lane, Chichester, West Sussex, England
25 Horaud, F. 1991. Introductory remark: viral safety of biologicals. Dev. Biol. Stand. 75: 3-7   PUBMED
26 Boschetti, N., K. Wyss, A. Mischler, T. Hostettler, and C. Kempf. 2003. Stability of minute virus of mice against temperature and sodium hydroxide. Biologicals 31: 181-185   DOI   ScienceOn
27 Nicklas, W., V. Kraft, and B. Meyer. 1993. Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab. Anim. Sci. 43: 296-300   PUBMED
28 Joung, J., S. Lee, S. Chang, J. Jeong, and Y. Sohn. Study for detection of adventious minute virus of mice from cell culture. Lab. Ani. Res. 21: 74-79